Sales decline 23.81% to Rs 30.81 crore
Net profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quarter ended September 2023. Sales declined 23.81% to Rs 30.81 crore in the quarter ended September 2024 as against Rs 40.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales30.8140.44 -24 OPM %16.5918.05 -PBDT3.996.45 -38 PBT1.205.54 -78 NP1.225.54 -78Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Sugar")
 "Vecmocon Co-founders - Adarshkumar Balaraman (COO); Shivam Wankhede (CTO); and Peeyush Asati (CEO)")
 "Ujjivan Small Finance Bank")
 "Alibaba")
 "Drone startup Airbound raises $1.7 million funding, to focus on deliveries")
